Related Experiment Videos
Mouse-protection experience with monovalent Pseudomonas aeruginosa vaccine
Abstract:
The protective effect of the soluble immunogenic complex from Pseudomonas aeruginosa cell surface was studied on white mice. Vaccines were prepared from a single strain by phenol-water extraction or via preparing the Zn-complex. The immunogenic complex which contained the Pseudomonas "common protective antigen" as well as endotoxin and exotoxins in the form of toxoid, provided reliable protection if it was administered with aluminium hydroxide as adjuvant in three consecutive doses of 10, 100 and 500 microgram per 0.2 ml per mouse at 5-7 day intervals. Under these conditions, the monovaccine produced in mice a 90-100% protective effect against a lethal challenge dose (2 LD100) of toxic P. aeruginosa strains given a week after the last vaccine dose.
Insights
A Pseudomonas aeruginosa vaccine derived from the bacterial cell surface demonstrated significant protection in mice. This immunogenic complex, when administered with an adjuvant, offered up to 100% protection against lethal bacterial challenge.
Area of Science:
- Immunology
- Microbiology
- Vaccine Development
Background:
- Pseudomonas aeruginosa is an opportunistic pathogen causing severe infections.
- Developing effective vaccines against P. aeruginosa remains a significant challenge.
- The bacterial cell surface contains potential targets for protective immunity.
Purpose of the Study:
- To evaluate the protective efficacy of a soluble immunogenic complex from P. aeruginosa.
- To assess vaccine formulations derived from phenol-water extraction and Zn-complex methods.
- To determine the optimal dosage and adjuvant for vaccine-induced protection.
Main Methods:
- Preparation of vaccines using phenol-water extraction and Zn-complex methods from P. aeruginosa.
- Administration of vaccines with aluminium hydroxide adjuvant in three escalating doses.
- Challenge studies in white mice using lethal doses (2 LD100) of toxic P. aeruginosa strains.
Main Results:
- The immunogenic complex, containing common protective antigen, endotoxins, and exotoxoids, induced reliable protection.
- A monovaccine administered with aluminium hydroxide adjuvant achieved 90-100% protection.
- Optimal protection was observed with doses of 10, 100, and 500 micrograms per mouse.
Conclusions:
- The soluble immunogenic complex from P. aeruginosa cell surface is a promising vaccine candidate.
- Aluminium hydroxide adjuvant enhances the protective effect of the monovaccine.
- A three-dose vaccination regimen provides substantial protection against lethal P. aeruginosa challenge.